Author: healthadmin

Archaeologists working at the Oxyrhynchus ruins in ancient Egypt have made a surprising discovery. It was a papyrus containing a line from Homer’s poem. Iliad It was discovered inside a Roman-era mummy from about 1,600 years ago. Researchers say this is the first time in archaeological history that a Greek literary text was intentionally incorporated into the mummification process. The discovery was made by the Oxyrhynchus Archaeological Mission, directed by Maite Mascourt and Esther Pons, through the Institute of Ancient Near East Research (IPOA) at the University of Barcelona. It originates from Al-Bafnasa, a modern town located on the ancient…

Read More

Although many young people use cannabis, its relationship with mood disorders characterized by intense positive emotions is poorly understood. A recent study of college students found that higher risk for bipolar spectrum disorder was associated with more cannabis-related disruptions in daily life, while experiencing higher levels of natural positive emotions was associated with less frequent cannabis use. These results were published in the Journal of Affective Disorders. Bipolar spectrum disorder is a mental health condition defined by severe mood swings. People with these disorders experience manic or hypomanic episodes. This condition is characterized by an abnormally elevated mood, increased energy,…

Read More

The good news is: Deaths from ischemic heart disease, which clogs coronary arteries, were cut by more than half in the United States from 1990 to 2023 thanks to better control of up to 12 risk factors. What remains controversial is that nearly nine out of 10 recent deaths could have been prevented if these risk factors had been better controlled. Much of the progress recorded since the inception of the Global Burden of Disease Study, published Wednesday in JAMA Cardiology, is due to deaths caused by smoking (33.3% decrease) and particulate air pollution (74.9% decrease). However, in the final…

Read More

Written by Walker Livingston, Carolina Public Press July 15, 2026 In rural Western North Carolina, mountainous landscapes, tree patterns, and other ecological phenomena can make it difficult to keep the power on. But when Tropical Storm Helen struck nearly two years ago, the power grid across the region was destroyed, leaving some areas without power for weeks. After Helen, sustainability advocates and state and local agencies came together to find ways to bring back greener buildings and prevent such widespread losses of power and water access from happening again. (Subscribe for free to Carolina Public Press’ Daily, Weekend, Election 2026…

Read More

Colorful pet geckos, which are unusually prone to developing cancer, could become an important new tool for researchers studying how tumors form and spread. Scientists say this naturally occurring cancer in animals could provide valuable insight into why some species are so vulnerable to the disease, while others are markedly resistant. The research was led by the University of Nottingham. BMC biologyidentified genetic changes associated with tumors in a special type of leopard gecko. Many of these changes involve the same genes and biological pathways associated with human cancer, raising the possibility that this reptile could help advance cancer research.…

Read More

BUNIA, Congo — The number of confirmed Ebola cases in Congo has reached 2,011, of which 754 have died, according to government data released in the evening. Officials say this is the fastest growing outbreak on record. Medical workers at Bunia General Hospital, the region’s largest medical center, went on strike on Wednesday, becoming the latest group to quit their jobs in the epicenter over payment issues. Medical professionals and other front-line workers barricaded hospital entrances, saying they were not being compensated for working in difficult conditions. The World Health Organization has announced that more than 100 healthcare workers have…

Read More

For millions of people, AI chatbots have become a new gateway to health information. More than 230 million people use ChatGPT to ask health questions every week. Healthcare is now OpenAI’s largest and fastest-growing use case, and the company has made significant inroads into the space, rolling out enterprise tools for hospitals and personal health assistants for consumers. OpenAI has set an audacious goal of “improving the health of all humanity” through AI, and Karan Singhal is leading the effort. Singhal, a leading artificial intelligence researcher who previously worked at Google, joined OpenAI two years ago as head of health…

Read More

AbbVie announced its largest acquisition in more than five years, agreeing to acquire Apogee Therapeutics for approximately $10.9 billion to further strengthen the company’s leadership in immunology and expand its pipeline of therapeutics for inflammatory diseases. The acquisition will give AbbVie access to Apogee’s lead candidate sumiloquivert (APG777), a late-stage monoclonal antibody in development for atopic dermatitis, asthma, and other inflammatory diseases. This therapy is of great interest in the industry as it potentially offers a more convenient dosing schedule compared to current standard treatments. The deal comes as pharmaceutical companies across the industry continue to invest heavily in innovative…

Read More

As artificial intelligence continues to transform capabilities across drug discovery, clinical development, manufacturing, commercial operations, and life sciences, senior HR and workforce transformation leaders are facing new strategic challenges on how to redesign jobs, skills, and operating models for an AI-enabled future. Generative AI is already reshaping the way life sciences organizations operate. McKinsey estimates that generative AI could create between $60 billion and $110 billion in annual economic value for the pharmaceutical and medical products industry, with impacts spanning research and early detection, clinical development, operations, commercial and medical affairs. Deloitte also highlighted that AI and GenAI are beginning…

Read More

As early access programs continue to expand across Europe, pharmaceutical and biotech teams are facing increased pressure to get investigational drugs to patients early while navigating fragmented national regulations, increasing expectations for real-world data, rare disease access challenges, and increasingly complex global program delivery. Early access programs, also known as expanded access, managed access, compassionate use, or prior authorization access programs, allow eligible patients with serious, life-threatening, or severely debilitating conditions to access investigational therapies outside of clinical trials when no satisfactory approved treatment options exist. Across Europe, these programs are becoming increasingly important within broader drug development and patient…

Read More